Has William Miller, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,493 in general payments to William Miller, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Miller, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Miller, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Miller, MD

Cardiovascular Disease · Fort Collins, CONPI 1821094988

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (38.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 68.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $6,070 and has fallen 96.5% since, to $214 in 2025.

$8,493in general payments, 2019–2025

Across 32 payments — averaging $265.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$6K
Cardiovascular Systems Inc.$1K
Penumbra, Inc.$831
Shockwave Medical, Inc$300
Boston Scientific$162
W. L. Gore & Associates, Inc.$113
plus $177 from 4 others

$134,036in research payments, 2019–2025

Across 42 payments — averaging $3191.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shockwave Medical, Inc$128K
Philips North America LLC$5K
Bard Peripheral Vascular, Inc.$1K

What the payments were for

Consulting fees$1,05012%
Speaking & faculty fees$3,30039%
Travel & lodging$1,15814%
Food & beverage$2,98635%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	16	$5,791
Cardiovascular Systems Inc.	2	$1,119
Penumbra, Inc.	2	$831
Shockwave Medical, Inc	5	$300
Boston Scientific	2	$162
W. L. Gore & Associates, Inc.	1	$113
Philips North America LLC	1	$79
Medtronic	1	$68
Merck	1	$15
Atricure, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Supera peripheral stent system$3,633
Peripheral Orbital Atherectomy System$1,050
Indigo System$831
Omnilink Elite vascular stent system$800
CARDIOMEMS$247
JETi All In One Non-Sterile Kit$240
ESPRIT$214
Emboshield NAV6 system$206
Vascular Lithotripsy$151
JETI$150
JETi Peripheral Catheter$142
VIABAHN VBX Balloon Expandable Endoprosthesis$113
Ranger$104

How this compares

$8,493 in reported general payments places this provider in the 85th percentile of 276 cardiovascular disease providers in Colorado.

See all cardiovascular disease providers in Colorado →

Medicare billing

Part B allowed, 2024

$206,818

Medicare patients

1,515

Services billed

2,325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	123	$182,657
XareltoRivaroxaban	54	$73,644
Varenicline Tartrate	21	$4,707
Metoprolol Succinate	222	$3,045
Atorvastatin Calcium	296	$2,826
Rosuvastatin Calcium	246	$2,716
ClopidogrelClopidogrel Bisulfate	249	$2,462
Clonidine	19	$2,399
Ezetimibe	83	$2,387
Olmesartan Medoxomil	117	$1,889
Losartan Potassium	141	$1,237
Diltiazem 24hr Er (Cd)Diltiazem Hcl	41	$1,227
Bumetanide	33	$1,227
Amiodarone Hcl	28	$1,219
Amlodipine Besylate	178	$1,200

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Fort Collins

Stephen TreatFort Collins$7K
Payal KohliAurora$1.7M
Marc BonacaAurora$703K
Andrew FreemanDenver$454K
William SauerAurora$365K
Jeffrey BooneGreenwood Village$287K
Rhonda MiyasakaAurora$128K
Gregory SchwartzAurora$122K
Deborah JalowiecColorado Springs$106K
Edward GillAurora$96K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →